Neuvivo
Palo Alto
About Neuvivo
Neuvivo is a private, late-clinical stage biopharmaceutical company committed to creating and delivering advanced treatments for ALS and other neurodegenerative diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $11.0M
- Last round: Series Unknown (Jun 2023)
- Website: neuvivo.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/neuvivo-126611 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.